when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Dermatology · news · pharmadog

← back to Dermatology

News · Dermatology

112 stories

Jul 22, 26Celldex ends skin disease program after failing phase 2 testfiercebiotech

Jul 17, 26Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advancesbiopharma dive

Jul 16, 26Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immunobiospace

Jul 16, 26Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 updatefiercebiotech

Jul 16, 26Racing Takeda, InnoCare reports TYK2 inhibitor win in phase 2 vitiligo trialfiercebiotech

Jul 16, 26Opinion: The growing fang-to-pharmacy pipelinestat

Jul 13, 26STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and morestat

Jul 10, 26ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadershipbiopharma dive

Jul 9, 26Opinion: Your grandparents are using cannabis. Doctors can help them do it safelystat

Jul 8, 26Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsstat

Jul 7, 26Vera Therapeutics wins FDA nod for closely watched kidney disease drugbiopharma dive

Jul 6, 26Convenience Kit Correction: Windstone Medical Packaging, Inc. Issues Correction for Convenience Kitfda medwatch

Jul 1, 26Abivax shares surge as worries subside over immune drug’s cancer riskbiopharma dive

Jun 29, 26Evommune's lead drug fails in chronic hives, stock sinksendpoints

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 15, 26Medicare drug price rule may target under-the-skin Keytruda and Opdivobiopharma dive

Jun 13, 26Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73stat

Jun 12, 26FDA Clears First Over-the-Counter Continuous Glucose Monitor for Childrenfda press

Jun 11, 26Takeda's plaque psoriasis pill beats Bristol Myers' Sotyktu in Phase 3endpoints

Jun 11, 26Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head testbiopharma dive

Jun 10, 26DOJ reaches second settlement on youth gender carestat

Jun 9, 26FDA OKs first new sunscreen ingredient in more than 25 yearsstat

Jun 9, 26FDA Expands Sunscreen Options for the First Time in 20 Yearsfda press

Jun 8, 26Incyte to buy blood disorder drug in possibly $2B dealbiopharma dive

Jun 8, 26When it’s time to save a limb, novel clinic meets unhoused people where they arestat

Jun 5, 26Study data convince Lundbeck to push new migraine drug forwardbiopharma dive

Jun 5, 26Opinion: How living and practicing medicine abroad complicated my beliefs about universal health care systemsstat

Jun 4, 26Supreme Court sides with Hikma in 'skinny label' caseendpoints

Jun 4, 26Male puberty is understudied — but when it starts may predict long-term health risksstat

Jun 2, 26Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trialbiopharma dive

← prevpage 3 of 4next →